Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs

Journal of Substance Abuse Treatment

Volumn 44, Issue 1, 2013, Pages 120-125

  Abraham, Amanda J ^a   O'Brien, Lauren A ^a   Knudsen, Hannah K ^b   Bride, Brian E ^a   Smith, G Rush ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

HIV testing; Substance use disorders; Treatment programs

Indexed keywords

AFRICAN AMERICAN; ARTICLE; FEMALE; GROUP THERAPY; HEALTH PROGRAM; HIGH RISK POPULATION; HISPANIC; HIV TEST; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED STATES;

AFRICAN AMERICANS; CLINICAL LABORATORY TECHNIQUES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); RISK FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNITED STATES;

EID: 84870236646     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.03.004     Document Type: Article

References (63)

1. Abraham A.J., Knudsen H.K., Rothrauff T.C., Roman P.M. The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation. Journal of Substance Abuse Treatment 2010, 38:275-283.
2. Abraham A.J., O'Brien L.A., Bride B.E., Roman P.M. HIV/AIDS services in private substance abuse treatment programs. Drug and Alcohol Dependence 2011, 115:16-22.
3. Bini E.J., Kritz S., Brown L.S., Robinson J., Alderson D., Rotrosen J. Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States. Journal of Addictive Diseases 2011, 30:98-109.
4. Blower S., Gershengorn H.B., Grant R. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000, 287:650-654.
5. Branson B.M. Rapid test for HIV antibody. AIDS Reviews 2000, 20:76-83.
6. Branson B.M., Handsfield H.H., Lampe M.A., Janssen R.S., Taylor A.W., Lyss S.B., et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Journal of the National Medical Association 2006, 100:131-147.
7. Brown L.S., Kritz S.A., Goldsmith R.J., Bini E.J., Rotrosen J., Baker S., et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2006, 30:315-321.
8. Centers for Disease Control and Prevention MMWR Weekly: Update: AIDS - United States, 2000 Retrieved August 8, 2011, from:. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5127a2.htm.
9. Centers for Disease Control and Prevention HIV Counseling and Testing at CDC-supported sites - United States, 1999 - 2004 2006, US Department of Health and Human Services, CDC, Atlanta, GA, Retrieved August 8, 2011, from:. http://www.cdc.gov/hiv/topics/testing/resources/reports/pdf/ctr04.pdf.
10. Centers for Disease Control and Prevention HIV/AIDS Surveillance Report 2006, Centers for Disease Control and Prevention, Atlanta, GA.
11. Centers for Disease Control and Prevention Expanded and Integrated Human Immunodeficiency Virus (HIV) Testing for Populations Disproportionately Affected by HIV, Primarily African Americans Retrieved August 8, 2011, from:. http://www.cdc.gov/od/pgo/funding/FOAs.htm.
12. Centers for Disease Control and Prevention HIV Surveillance Report 2008, Centers for Disease Control and Prevention, Atlanta, GA.
13. Centers for Disease Control and Prevention HIV Surveillance Report 2009, Centers for Disease Control and Prevention, Atlanta, GA.
14. Centers for Disease Control and Prevention HIV Testing Among Adolescents 2009, Centers for Disease Control and Prevention, Atlanta, GA.
15. Centers for Disease Control and Prevention HIV in the United States 2010, Centers for Disease Control and Prevention, Atlanta, GA.
16. Colfax G.N., Mansergh G., Guzman R., Vittinghoff E., Marks G., Rader M., et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison. JAIDS Journal of Acquired Immune Deficiency Syndromes 2001, 28:373-379.
17. D'Aunno T., Vaughn T.E., McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior 1999, 40:175-192.
18. Dorn S., Buettgens M. Net Effects of the Affordable Care Act on State Budgets 2010, Urban Institute, Washington, DC, Retrieved September 10, 2011, from. http://www.urban.org/UploadedPDF/1001480-Affordable-Care-Act.pdf.
19. Dreisbach S., Hickler B., Koester S. Methamphetamine use in rural Colorado: Health risks and community challenges 2004, Association for Prevention Teaching and Research, Washington, DC.
20. Ducharme L.J., Knudsen H.K., Roman P.M., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32:321-329.
21. Estrada A.L. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Reports 2002, 117:S126-S134.
22. Friedmann P.D., D'Aunno T.A., Jin L., Alexander J.A. Medical and psychosocial services in drug abuse treatment: Do stronger linkages promote client utilization?. Health Services Research 2000, 35:443-465.
23. Gorman E.M., Nelson K. From a far place: Social and cultural considerations about HIV among midlife and older gay men. Gay and Lesbian Aging: Research and Future Directions 2004, 73-96. Springer, New York. G.H. Herdt, B. De Vries (Eds.).
24. Grigoryan A., Shouse R.L., Durant T., Mastro T.D., Espinoza L., Chen M., et al. HIV infection among injection-drug users-34 states. Journal of the American Medical Association 2010, 303:126-128.
25. Guerrero E.G., Cedarbaum J.A. Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. International Journal on Drug Policy 2011, 22:41-48.
26. Haynes L., Korte J., Holmes B., Gooden L., Matheson T., Feaster D., et al. HIV rapid testing in substance abuse treatment: Implementation following a clinical trial. Evaluation and Program Planning 2011, 34:399-406.
27. Horton T., Uniyal A., Smith L., Curreri S., Kerndt P., Branson B. Feasibility of Implementing Rapid HIV Testing in a Community-Based Setting 2003, July.
28. Jorgensen J. Budget cuts threaten future of drug, alcohol treatment programs. Eagle-Tribune Retrieved September 9, 2011, from:. http://www.eagletribune.com/latestnews/x340279125/Budget-cuts-threaten-future-of-drug-alcohol-treatment-programs.
29. Kaiser Family Foundation Updated Fact Sheet: HIV Testing in the United States Retrieved September 9, 2011, from:. http://www.kff.org/hivaids/6094.cfm.
30. Kallenborn J.C., Price T.G., Carrico R., Davidson A.B. Emergency department management of occupational exposures: Cost analysis of rapid HIV test. Infection Control and Hospital Epidemiology 2001, 22:289-293.
31. Kassler W.J., Dillon B.A., Haley C., Jones W.K., Goldman A. On-site, rapid HIV testing with same-day results and counseling. AIDS 1997, 11:1045.
32. Knudsen H.K., Abraham A.J., Oser C.B. Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Evaluation and Program Planning 2011, 34:375-381.
33. Knudsen H.K., Oser C.B. Availability of HIV-related health services in adolescent substance abuse treatment programs. AIDS Care 2009, 21:1238-1246.
34. Knudsen H.K., Roman P.M., Oser C.B. Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. Journal of Addiction Medicine 2010, 4:99-107.
35. Kritz S., Brown L.S., Goldsmith J., Bini E.J., Robinson J., Alderson D., et al. States and substance abuse treatment programs: Funding and guidelines for infection-related services. American Journal of Public Health 2008, 98:824-826.
36. Long J.S. Regression models for categorical and limited dependent variables 1997, Sage, Thousand Oaks, CA.
37. Marks G., Crepaz N., Janssen R.S. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006, 20:1447-1450.
38. McCarty D., Fuller B., Kaskutas L.A., Wendt W.W., Nunes E.V., Miller M., et al. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug and Alcohol Dependence 2008, 92:200-207.
39. McCree D.H., Jones K.T., O'Leary A. African Americans and HIV/AIDS: Understanding and addressing the epidemic 2010, Springer, New York.
40. Mee-Lee D., Gartner L., Miller M.M., Shulman G., Wilford B.B. ASAM patient placement criteria for the treatment of psychoactive substance use disorders 1996, American Society of Addiction Medicine, Chevy Chase, MD. 2nd ed.
41. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 1993, 6:1049.
42. Molitor F., Truax S.R., Ruiz J.D., Sun R.K. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. Western Journal of Medicine 1998, 168:93-97.
43. National Alliance of State & Territorial AIDS Directors Report on the Centers for Disease Control and Prevention (CDC) expanded testing initiative: Successes and challenges for Health Department HIV/AIDS programs 2009, the National Alliance of State & Territorial AIDS Directors (NASTAD), Washington, DC.
44. National Medical Association NMA HIV/AIDS Program Retrieved September 9, 2011, from:. http://www.nmanet.org/HIVJoomla/index.php/program.
45. Otten M.W., Zaidi A.A., Wroten J.E., Witte J.J., Peterman T.A. Changes in sexually transmitted disease rates after HIV testing and posttest counseling, Miami, 1988 to 1989. American Journal of Public Health 1993, 83:529-533.
46. Pollack H.A., D'Aunno T. HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. Journal of Substance Abuse Treatment 2010, 38:307-316.
47. Pollack H.A., D'Aunno T., Lamar B. Outpatient substance abuse treatment and HIV prevention: An update. Journal of Substance Abuse Treatment 2006, 30:39-47.
48. Porco T.C., Martin J.N., Page-Shafer K.A., Cheng A., Charlebois E., Grant R.M., et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004, 18:81-88.
49. Rogers E.M. Diffusion of innovations 2003, Free Press, New York. 5th ed.
50. Roman P.M., Abraham A.J., Rothrauff T.C., Knudsen H.K. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2010, 38:S44-S52.
51. Rothman J., Rudnick D., Slifer M., Agins B., Heiner K., Birkhead G. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: A model for effective service delivery to a high-risk population. Journal of Urban Health 2007, 84:226-242.
52. Shrestha R.K., Clark H.A., Sansom S.L., Song B., Buckendahl H., Calhoun C.B., et al. Cost-effectiveness of finding new diagnosis using rapid HIV testing in community-based organizations. Public Health Reports 2008, 123:94-100.
53. StataCorp Stata Statistical Software: Version 11.0 2009, StataCorp LP, College Station, TX.
54. Strauss S.M., Des Jarlais D.C., Astone J., Vassilev Z.P. On-site HIV testing in residential drug treatment units: Results of a nationwide survey. Public Health Reports 2003, 118:37-43.
55. Substance Abuse and Mental Health Services Administration Substance Abuse Treatment for Persons with HIV/AIDS: Treatment Improvement Protocol (TIP) Series, Number 37 2000, US Government Printing Office, Washington, DC, (DHHS Pub. No. (SMA) 00-3410).
56. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality The N-SSATS report: HIV services offered by substance abuse treatment facilities 2010, Substance Abuse and Mental Health Services Administration, Rockville, MD.
57. The White House Office of National AIDS Policy National HIV/AIDS Strategy for the United States Retrieved October 1, 2011, from:. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.
58. Tortu S., Beardsley M., Deren S., Davis W.R. The risk of HIV infection in a national sample of women with injection drug-using partners. American Journal of Public Health 1994, 84:1243-1249.
59. Umbricht-Schneiter A., Ginn D.H., Pabst K.M., Bigelow G.E. Providing medical care to methadone clinic patients: Referral vs on-site care. American Journal of Public Health 1994, 84:207-210.
60. Volkow N.D., Montaner J. Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA : The Journal of the American Medical Association 2010, 303:1423-1424.
61. Volkow N.D., Montaner J. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Affairs 2011, 30:1411-1419.
62. Walsh J. Statement of James Walsh, President, NAMI Alabama on behalf of the National Alliance on Mental Illness congressional briefing: Impact of the economic crisis on the America's public mental health safety net Retrieved October 1, 2011, from:. http://www.nami.org/Template.cfm?Section=February20&Template=/ContentManagement/ContentDisplay.cfm&ContentID=115834.
63. Winstock A.R., Anderson C.M., Sheridan J. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Medical Journal of Australia 2006, 184:560-562.